EXAS
Exact Sciences Corp
Price:  
53.52 
USD
Volume:  
1,266,159.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS Relative Valuation

-270.2%
Upside

As of 2025-06-16, the Relative Valuation of Exact Sciences Corp (EXAS) is (91.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 53.52 USD, the upside of Exact Sciences Corp based on Relative Valuation is -270.2%.

The range of the Relative Valuation is (66.28) - (111.48) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.3x - 20.8x 18.2x
Forward P/E multiples 9.9x - 20.6x 15.4x
Fair Price (66.28) - (111.48) (91.10)
Upside -223.8% - -308.3% -270.2%
53.52 USD
Stock Price
(91.10) USD
Fair Price

EXAS Relative Valuation - Historical P/E Data

Date P/E
2025-06-13 -9.90
2025-06-12 -9.99
2025-06-11 -10.30
2025-06-10 -10.39
2025-06-09 -10.10
2025-06-06 -10.15
2025-06-05 -10.06
2025-06-04 -10.20
2025-06-03 -10.14
2025-06-02 -10.38
2025-05-30 -10.41
2025-05-29 -10.66
2025-05-28 -10.74
2025-05-27 -10.46
2025-05-23 -10.53
2025-05-22 -10.45
2025-05-21 -10.52
2025-05-20 -10.69
2025-05-19 -10.53
2025-05-16 -10.44
2025-05-15 -10.39
2025-05-14 -10.15
2025-05-13 -9.93
2025-05-12 -9.88
2025-05-09 -9.55
2025-05-08 -9.81
2025-05-07 -9.86
2025-05-06 -9.99
2025-05-05 -9.86
2025-05-02 -9.54
2025-05-01 -8.72
2025-04-30 -8.44
2025-04-29 -8.28
2025-04-28 -8.43
2025-04-25 -8.41
2025-04-24 -8.43
2025-04-23 -8.16
2025-04-22 -8.17
2025-04-21 -7.97
2025-04-17 -7.69
2025-04-16 -7.82
2025-04-15 -8.08
2025-04-14 -8.18
2025-04-11 -8.22
2025-04-10 -8.09
2025-04-09 -8.42
2025-04-08 -7.46
2025-04-07 -8.11
2025-04-04 -7.87
2025-04-03 -8.19